Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125494541 | 12549454 | 1 | I | 2013 | 20160621 | 20160712 | 20160712 | EXP | ES-009507513-1606ESP013077 | MERCK | 55.00 | YR | F | Y | 82.00000 | KG | 20160712 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125494541 | 12549454 | 1 | PS | CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | 1 | 70 MG, ONCE, FIRST DAY | 21227 | 70 | MG | INJECTION | 1X | |||||||
| 125494541 | 12549454 | 2 | SS | CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | 1 | 50 MG/24 H | 21227 | 50 | MG | INJECTION | QD | |||||||
| 125494541 | 12549454 | 3 | SS | VORICONAZOLE. | VORICONAZOLE | 1 | Intravenous (not otherwise specified) | 6 MG/KG, BID, FOR 1 DAY | 0 | 6 | MG/KG | BID | |||||||
| 125494541 | 12549454 | 4 | SS | VORICONAZOLE. | VORICONAZOLE | 1 | Intravenous (not otherwise specified) | 4 MG/KG, BID | 0 | 4 | MG/KG | BID | |||||||
| 125494541 | 12549454 | 5 | SS | VORICONAZOLE. | VORICONAZOLE | 1 | Intravenous (not otherwise specified) | 600 MG, QD | 0 | 600 | MG | QD | |||||||
| 125494541 | 12549454 | 6 | SS | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | Respiratory (inhalation) | 25 MG, Q12H, NEBULIZED | 0 | 25 | MG | Q12H | |||||||
| 125494541 | 12549454 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | TABLET | QD | |||||
| 125494541 | 12549454 | 8 | C | amoxicillin (+) clavulanic acid | AMOXICILLINCLAVULANIC ACID | 1 | Intravenous (not otherwise specified) | 1 G/ 8H | U | 0 | 1 | G | Q8H | ||||||
| 125494541 | 12549454 | 9 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 250 MG/ DAY | U | 0 | 250 | MG | INJECTION | QD | |||||
| 125494541 | 12549454 | 10 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Intravenous (not otherwise specified) | 100 MG/ DAY | U | 0 | 100 | MG | CAPSULE | QD | |||||
| 125494541 | 12549454 | 11 | C | CISATRACURIUM BESYLATE. | CISATRACURIUM BESYLATE | 1 | Intravenous (not otherwise specified) | 150 MG/ D | U | 0 | 150 | MG | QD | ||||||
| 125494541 | 12549454 | 12 | C | HEPARIN SODIUM. | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | 120U-240U/DAY | U | 0 | SOLUTION FOR INJECTION | QD | |||||||
| 125494541 | 12549454 | 13 | C | HEPARIN SODIUM. | HEPARIN SODIUM | 1 | U | 0 | SOLUTION FOR INJECTION | ||||||||||
| 125494541 | 12549454 | 14 | C | NOREPINEPHRINE | NOREPINEPHRINENOREPINEPHRINE BITARTRATE | 1 | Intravenous (not otherwise specified) | 0.1-0.4 MG/H | U | 0 | /hr | ||||||||
| 125494541 | 12549454 | 15 | C | salbutamol | ALBUTEROL | 1 | Intravenous (not otherwise specified) | 5 MG/ H | 360 | MG | U | 0 | 5 | MG | /hr | ||||
| 125494541 | 12549454 | 16 | C | salbutamol | ALBUTEROL | 1 | Respiratory (inhalation) | 2.5 MG/ 8H, NEBULIZED | 360 | MG | U | 0 | 2.5 | MG | Q8H | ||||
| 125494541 | 12549454 | 17 | C | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | 500 MICROGRAM, Q8H, NEBULIZED | U | 0 | 500 | UG | Q8H | ||||||
| 125494541 | 12549454 | 18 | C | BUDESONIDE. | BUDESONIDE | 1 | Respiratory (inhalation) | 0.5 MG/ 8H, NEBULIZED | U | 0 | .5 | MG | Q8H | ||||||
| 125494541 | 12549454 | 19 | C | MAGNESIUM SULFATE. | MAGNESIUM SULFATE | 1 | Respiratory (inhalation) | 1.5 MG/ 8H, NEBULIZED | U | 0 | 1.5 | MG | Q8H | ||||||
| 125494541 | 12549454 | 20 | C | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 4 G/ 8H | U | 0 | 4 | G | Q8H | ||||||
| 125494541 | 12549454 | 21 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Intravenous (not otherwise specified) | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 125494541 | 12549454 | 22 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Intravenous (not otherwise specified) | 0-1 G/8H | U | 0 | Q8H | ||||||||
| 125494541 | 12549454 | 23 | C | METHYLPREDNISOLONE SODIUM SUCCINATE. | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 600 MG, QD | U | 0 | 600 | MG | SOLUTION FOR INJECTION | QD | |||||
| 125494541 | 12549454 | 24 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Intravenous (not otherwise specified) | 0-30MG/D (IV/ENTERAL) | U | 0 | QD | ||||||||
| 125494541 | 12549454 | 25 | C | IRON (UNSPECIFIED) | IRON | 1 | Intravenous (not otherwise specified) | 100 MG, UNK | U | 0 | 100 | MG | |||||||
| 125494541 | 12549454 | 26 | C | FOLIC ACID. | FOLIC ACID | 1 | Intravenous (not otherwise specified) | 50 MG, UNK | U | 0 | 50 | MG | |||||||
| 125494541 | 12549454 | 27 | C | cyanocobalamin (+) pyridoxine (+) thiamine | 2 | Intravenous (not otherwise specified) | 1 AMPOULE, UNK | U | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125494541 | 12549454 | 1 | Bronchopulmonary aspergillosis |
| 125494541 | 12549454 | 3 | Bronchopulmonary aspergillosis |
| 125494541 | 12549454 | 6 | Bronchopulmonary aspergillosis |
| 125494541 | 12549454 | 7 | Dyslipidaemia |
| 125494541 | 12549454 | 8 | Antibiotic therapy |
| 125494541 | 12549454 | 9 | Sedation |
| 125494541 | 12549454 | 10 | Analgesic therapy |
| 125494541 | 12549454 | 11 | Muscle relaxant therapy |
| 125494541 | 12549454 | 12 | Extracorporeal membrane oxygenation |
| 125494541 | 12549454 | 13 | Anticoagulant therapy |
| 125494541 | 12549454 | 14 | Shock |
| 125494541 | 12549454 | 15 | Bronchospasm |
| 125494541 | 12549454 | 17 | Bronchospasm |
| 125494541 | 12549454 | 18 | Bronchospasm |
| 125494541 | 12549454 | 19 | Bronchospasm |
| 125494541 | 12549454 | 20 | Antibiotic therapy |
| 125494541 | 12549454 | 21 | Antifungal treatment |
| 125494541 | 12549454 | 22 | Pyrexia |
| 125494541 | 12549454 | 23 | Antiinflammatory therapy |
| 125494541 | 12549454 | 25 | Mineral supplementation |
| 125494541 | 12549454 | 26 | Vitamin supplementation |
| 125494541 | 12549454 | 27 | Vitamin supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125494541 | 12549454 | OT |
| 125494541 | 12549454 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125494541 | 12549454 | Drug ineffective | |
| 125494541 | 12549454 | Multiple organ dysfunction syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125494541 | 12549454 | 1 | 20130225 | 20130225 | 0 | |
| 125494541 | 12549454 | 2 | 20130226 | 20130306 | 0 | |
| 125494541 | 12549454 | 3 | 201302 | 201302 | 0 | |
| 125494541 | 12549454 | 4 | 201302 | 201302 | 0 | |
| 125494541 | 12549454 | 5 | 20130226 | 20130306 | 0 | |
| 125494541 | 12549454 | 6 | 20130228 | 20130306 | 0 | |
| 125494541 | 12549454 | 8 | 20130218 | 20130221 | 0 | |
| 125494541 | 12549454 | 9 | 20130221 | 20130306 | 0 | |
| 125494541 | 12549454 | 10 | 20130221 | 20130306 | 0 | |
| 125494541 | 12549454 | 11 | 20130222 | 20130306 | 0 | |
| 125494541 | 12549454 | 12 | 20130222 | 20130306 | 0 | |
| 125494541 | 12549454 | 14 | 20130222 | 20130306 | 0 | |
| 125494541 | 12549454 | 15 | 20130222 | 20130225 | 0 | |
| 125494541 | 12549454 | 16 | 20130225 | 20130306 | 0 | |
| 125494541 | 12549454 | 17 | 20130221 | 20130306 | 0 | |
| 125494541 | 12549454 | 18 | 20130221 | 20130306 | 0 | |
| 125494541 | 12549454 | 19 | 20130222 | 20130225 | 0 | |
| 125494541 | 12549454 | 20 | 20130221 | 20130227 | 0 | |
| 125494541 | 12549454 | 21 | 20130225 | 20130226 | 0 | |
| 125494541 | 12549454 | 22 | 20130221 | 20130306 | 0 | |
| 125494541 | 12549454 | 23 | 20130221 | 20130306 | 0 | |
| 125494541 | 12549454 | 24 | 20130221 | 20130306 | 0 | |
| 125494541 | 12549454 | 25 | 20130227 | 20130227 | 0 | |
| 125494541 | 12549454 | 26 | 20130227 | 20130227 | 0 | |
| 125494541 | 12549454 | 27 | 20130227 | 20130306 | 0 |